|
Haryana set to become hub of
medical devices as around 100 industrial units set up plants in the state
Haryana, the erstwhile popular hub of
pharmaceutical formulations in the northern part of the country, is now turning
out to be the centre of the medical devices industry to manufacture and sell
elite medical diagnostic instruments.
Around 100 medical devices industrial units have
already established their plants in the state at Karnal.
This exponential rise in the number of
manufacturing units for medical instruments and equipment is happening at a time
when many formulation units are closing down their production facilities and
moving out of the business sector due to lack of supportive industrial policies,
says P K Gupta, president of the Haryana Pharmaceutical Manufacturers
Association (HPMA).
He said, among other issues, bureaucracy is the
main hurdle for the development of the small scale industry sector in Haryana.
“The industry policies of the government most often
become detrimental to the growth of small scale units, or otherwise I would say
that bureaucracy is the main hurdle for the growth of the SSI sector. This is
not only for the pharma manufacturing industry, but for all the industries. In
Haryana, I understand that about 10% of the total units were closed down due to
cumbersome regulatory policies and several more units are shrinking now without
any growth. The industry cannot survive if there is no business growth as the
day-to-day expenses are increasing without limit. In addition to this, the
regulatory department is also acting not supportive to the industries.”
However, Gupta said, the state government brings
out certain attractive projects to retain the existing units and tries to bring
more companies to Haryana for a sustainable pharma market. But the implementing
agencies do not act properly for the development of the industry.
HPMA finds that the government’s industry as well
as regulatory policies helps only the multinational giants and the medium level
players. Such companies will remain, and the SSI units will vanish from the
scene very shortly unless the government takes a favorable stance towards the
small scale players.
“In an interaction with Pharmabiz, the president of
the HPMA said Haryana was once a prosperous industry base for pharmaceutical
formulations and it was on the top. On every one out of three strips of
medicines, one Haryana based manufacturer’s name was there. About 25 years ago
there were 300 actively operating manufacturing units which supplied medications
to the entire nation. When the rigorous Schedule M norms came, Haryana
Pharmaceutical Manufacturers Association worked very hard along with the
government to upgrade the technologies in the facilities of the companies to
become at par with global regulations and enhance the capacities. However, in
later years due to tax free benefits in Uttarakhand and Himachal Pradesh states,
several units closed down their facilities here and moved to those states taking
incentives. Gradually the Haryana pharmaceutical sector lost its wonderful
industry atmosphere”, said Gupta.
On the side of challenges faced by the pharma
sector, the industry visionary said unlike south Indian states the
pharmaceutical manufacturers in Haryana faces one crucial problem and that is
with regard to technical personnel and skilled labourers. As regards raw
materials and distributors, they have no issues. But availability of
technical-hands for the industry still continues to be a burning issue.
Talking about the developmental activities in the
manufacturing sector, PK Gupta said HPMA is taking initiative with the
government to set up one Pharma Park in Karnal. There is a proposal from the
central government to set up one API Park and a medical devices park somewhere
in Haryana. State government has good vision about the future prospects of the
pharmaceutical sector although they do not provide any help for the SSIs. “We
are hopeful that one pharma park will be set up in the state somehow”.
http://pharmabiz.com/NewsDetails.aspx?aid=134315&sid=1.
Emerging trends in Indian healthcare
industry
Neelesh Shinde
Chief Technical Officer
Jupiter Hospital, Mumbai
During this COVID-19 pandemic, the entire
healthcare industry is facing issues like sudden demand for personal protective
equipment, consumables, medicines as well as medical equipment and
simultaneously there is a major decrease in revenues. It has become imperative
to find innovative ways to make the industry self-sustaining and back on the
growth curve.
Healthcare leaders are looking to the supply chain
and procurement process to enhance operational efficiency through various
emerging trends to get quality but affordable products.
When we say quality, it is not only longevity/the
physical sturdiness of the product but also the technology and sensitivity of
the product. Indigenous products must also strive to develop products whose
algorithms match with their international counterparts.
At Jupiter hospital, as an organization’s
philosophy, we have never compromised on technology. We strongly believe that
such investments are done for a decade. What is best today, might be just usable
after 10 years. So we have to look for latest technology, which will last for at
least 10 years without getting obsolete. Obsolescence is a big challenge in
healthcare.
Even in the pre-COVID era, digitization was
considered the best way to transform businesses, but around the world, the
pandemic situation has prioritized patient centric remote monitoring solutions
and deployment of non-contact technologies.
Some of the new trends which will impact patient
care in near future across hospital industry include:
Virtual critical care center help in giving
clinical real time decision support by clinical expertise. This type of centre
can monitor multiple peripheral ICUs on a 24×7 basis. This will take clinical
expertise from the metro/city to the rural parts of India
IoMT (Internet of Medical Things) could radically
help digitize key hospital areas like the ICUs, and operating rooms. An
ecosystem could be created wherein ICU’s major equipment like ventilators,
patient monitors, syringe and infusion pumps and anesthesia machines, navigation
systems, HVAC systems etc in OTs could be synced with the hospital information
system.
A robust integrated hospital information and lab
information systems could help minimize documentation time. This could
potentially reduce the documentation work for nursing/caregivers and more
quality time could be spent with patients in handling them. This could have a
direct bearing on the patient outcome.
Similarly a good EMR (electronic medical record)
could make information like length of stay, mortality rate, bed occupancy,
device utilization, and much more clinical and management information at the
click of a button.
Tele OPD/telemedicine will enhance patient
satisfactory experience. This is especially so in the current COVID-19 times
wherein patients are preferring to consult a doctor from the comfort of their
homes unless it is advised by the consultant to consult in person.
Home Health (healthcare at patient’s doorstep).
This technology can help patients to reduce cost and improve quality of life by
tracking vital parameters, sleep and respiratory monitoring, prenatal monitoring
and integrating that data with electronic medical records.
Combination of these data can translate into
actionable treatment plan where patient also will be able to track their health
parameters. Traditionally this has been used for old patients, end of life,
geriatric patients who needs monitoring more than active clinical intervention.
Artificial Intelligence (AI)
solution is a great step to enhance quality with accessibility. During COVID
pandemic AI in the mobile X-ray solution has enabled to detect and diagnose an
early as well as advance pneumothorax.
Due to that prioritization can be
done for more critical patients. This will also help in patient’s care
standardization. In latest CT scanners we can use AI algorithms for reduction in
radiation dosages as well as contrast media. During COVID-19 pandemic AI based
voice analysis application has been developed to detect COVID patients as a
pilot study.
Robotic guided systems gives
precision, predictable, and accurate results. The new robotic system is use with
neurosurgical instruments for stereo electroencephalography (SEEG) depth
electrode placement as well as in biopsy. (SEEG) is a minimally invasive
surgical procedure that is used to identify areas of the brain where epileptic
seizures originate. During SEEG, doctors place electrodes in targeted brain
areas, which are then monitored to precisely locate the source of the seizure.
MRI guided laser ablation. Guided
laser ablation is a minimally invasive neurosurgical technique for a number of
diseases, including brain tumors. Compared to traditional open surgery
(craniotomy) to remove a brain tumor, MRI-guided laser ablation can reduce pain
after surgery and shorten recovery time.
Ventilators modes and trends. A
visualization tool to monitor the pressures responsible for exchange of gases
with respect to a certain value to prevent possibilities of barotrauma. Tool,
which can also monitor changing patterns of delivered tidal volume with respect
to the predicted body weight.
Sophisticated dual limb ICU
ventilator which has facility of non-invasive ventilation with excellent
automatic leakage compensation due to which pressure parameters need not be kept
higher. HFNC which can deliver higher flows of oxygen up to 60l/min. A dual mode
(control and support mode) feature we can use as per patient’s response and this
also reduces the sedation to the patient as well as start weaning the patient
from very first breath. Breath by breath pressure in lung during gas exchange
setting the trend for patient care during ARDS.
New innovations in immunoassay and
clinical chemistry analyzers. In Jupiter Hospital we have installed Siemens’s
Atellica machine, which include features like automated calibration and QC;
Atellica Magline transport-patented, rapid, bidirectional, variable-speed sample
transport system that delivers samples to and from analyzers; Multi-camera
vision system-thereby saving time in tube identification and also reduce
bar-code reading errors; Automated maintenance; and highest productivity per
square meter; Ortho Clinical Diagnostics’ VITROS XT MicroSlides, featuring new,
multi-test technology that allows labs to run two tests simultaneously on one
MicroSlide, have been cleared for market by the US Food and Drug Administration.
Magnetic resonance imaging:
Breakthrough in MRI coils. The engineering breakthrough in MRI coils by
introducing AIR Coils, which are truly lightweight, flexible design, allowing
greater positioning freedom and a comfortable patient experience.
Outlook
Challenge is that all these new
trends will be currently available with all foreign manufacturers but those
software /hardware solutions has to become affordable so that various healthcare
providers will invest into that so supplier has to come with out of box’ options
like # Pay for Use # Short term rentals # Buy now pay later to customer.
Hon’ble PM, Narendra Modi has also
laid emphasis on vocal about local campaign to make India self-dependent. We
need to promote local healthcare start-ups who are active in healthcare
transformation with their innovative ideas.
https://www.medicalbuyer.co.in/services/emerging-trends-in-indian-healthcare-industry/
|
